Lung Cancer Awareness Month 2023

Lung Cancer Considered hosts Dr. Narjust Florez & Dr. Stephen Liu recap #WCLC23, discussing the meeting's most impactful research, including data presented on the MARS2, FLAURA2, TRIDENT, HERTHENA, & TROPION studies. With guests Dr. Stephanie Saw, from the National Cancer Center Singapore & Dr. Alfredo Addeo, from the University of Geneva.

Host Dr. Narjust Florez engages with three leading lung cancer patient advocates on the importance of patient advocacy groups, how these were formed, challenges when managing large patient advocacy groups and the future of patient advocacy in lung cancer. 

Dr. Hilary Robbins, an epidemiologist with the International Agency for Research on Cancer, and Dr. Brendon Stiles, chief of Thoracic Surgery and Surgical Oncology at Montefiore-Einstein Cancer Center in New York, join Lung Cancer Considered host Dr. Stephen Liu to discuss the current status of lung cancer screening research and challenges to implementing it on a national and international scale.

Globally, lung cancer is the single most lethal cancer, accounting for 1.8 million deaths last year, yet research funding devoted to lung cancer pales in comparison to other cancer types. In this episode of Lung Cancer Considered, host Dr. Stephen Liu discusses how global advocacy might play a role in addressing this gap. His guest is Dr. Anne-Marie Baird, a cancer researcher at Trinity College in Dublin, Ireland. Dr. Baird is the former Chair of the IASLC Communications Committee, and the newly appointed President of Lung Cancer Europe, a European platform for lung cancer advocacy.